missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human Neprilysin-2/MMEL1 Antibody, R&D Systems™

Mouse Monoclonal Antibody
Brand: R&D Systems MAB2340-SP
This item is not returnable.
View return policy
Description
Neprilysin-2/MMEL1 Monoclonal specifically detects Neprilysin-2/MMEL1 in Human samples. It is validated for Western Blot, Immunoprecipitation.
Specifications
| Neprilysin-2/MMEL1 | |
| Monoclonal | |
| LYOPH | |
| Western Blot 1 ug/mL, Immunoprecipitation 25 ug/mL | |
| Q495T6 | |
| MMEL1 | |
| Mouse myeloma cell line NS0-derived recombinant human Neprilysin-2 Gly78-Trp779 Accession # Q495T6 | |
| 25 μg | |
| Primary | |
| Detects human Neprilysin-2/MMEL1 in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) Neprilysin, rhECE-1 or rhECE-2 is observed. | |
| Human | |
| Purified |
| Western Blot, Immunoprecipitation | |
| 353207 | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| EC 3.4.24, EC 3.4.24.11, MELL1, membrane metallo-endopeptidase-like 1, Membrane metallo-endopeptidase-like 2MGC119455, MGC119454, MMEL1, MMEL2, NEP2, NEP2(m), NEPIIMGC119456, Neprilysin II, neprilysin-2, Neprilysin2, NL2, NL2NL1, SEP, soluble secreted endopeptidase, zinc metallopeptidase | |
| Mouse | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| 79258 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
| IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction